These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 12750302)

  • 1. Tachy- or bradyarrhythmias: implications for therapeutic intervention in LQT3 families.
    Glatter KA; Chiamvimonvat N
    Circ Res; 2003 May; 92(9):941-3. PubMed ID: 12750302
    [No Abstract]   [Full Text] [Related]  

  • 2. Contribution of sodium channel mutations to bradycardia and sinus node dysfunction in LQT3 families.
    Veldkamp MW; Wilders R; Baartscheer A; Zegers JG; Bezzina CR; Wilde AA
    Circ Res; 2003 May; 92(9):976-83. PubMed ID: 12676817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel SCN5A mutation manifests as a malignant form of long QT syndrome with perinatal onset of tachycardia/bradycardia.
    Chang CC; Acharfi S; Wu MH; Chiang FT; Wang JK; Sung TC; Chahine M
    Cardiovasc Res; 2004 Nov; 64(2):268-78. PubMed ID: 15485686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overlap syndrome of cardiac sodium channel disease in mice carrying the equivalent mutation of human SCN5A-1795insD.
    Remme CA; Verkerk AO; Nuyens D; van Ginneken AC; van Brunschot S; Belterman CN; Wilders R; van Roon MA; Tan HL; Wilde AA; Carmeliet P; de Bakker JM; Veldkamp MW; Bezzina CR
    Circulation; 2006 Dec; 114(24):2584-94. PubMed ID: 17145985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural heart disease, SCN5A gene mutations, and Brugada syndrome: a complex ménage à trois.
    Saffitz JE
    Circulation; 2005 Dec; 112(24):3672-4. PubMed ID: 16344397
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-QT syndrome-related sodium channel mutations probed by the dynamic action potential clamp technique.
    Berecki G; Zegers JG; Bhuiyan ZA; Verkerk AO; Wilders R; van Ginneken AC
    J Physiol; 2006 Jan; 570(Pt 2):237-50. PubMed ID: 16254012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The long QT interval syndrome].
    Heinc P
    Vnitr Lek; 2003 Oct; 49(10):813-9. PubMed ID: 14682155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A molecular basis for the therapy of the long QT syndrome.
    Priori SG; Napolitano C; Schwartz PJ
    Arch Mal Coeur Vaiss; 1996 Sep; 89(9):1185-7. PubMed ID: 8952843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New mechanism contributing to drug-induced arrhythmia: rescue of a misprocessed LQT3 mutant.
    Liu K; Yang T; Viswanathan PC; Roden DM
    Circulation; 2005 Nov; 112(21):3239-46. PubMed ID: 16301357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital long QT syndrome and 2:1 atrioventricular block with a mutation of the SCN5A gene.
    Miura M; Yamagishi H; Morikawa Y; Matsuoka R
    Pediatr Cardiol; 2003; 24(1):70-2. PubMed ID: 12574983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a relation between SIDS and long QT syndrome?
    Skinner JR
    Arch Dis Child; 2005 May; 90(5):445-9. PubMed ID: 15851422
    [No Abstract]   [Full Text] [Related]  

  • 12. A mutation in the human cardiac sodium channel (E161K) contributes to sick sinus syndrome, conduction disease and Brugada syndrome in two families.
    Smits JP; Koopmann TT; Wilders R; Veldkamp MW; Opthof T; Bhuiyan ZA; Mannens MM; Balser JR; Tan HL; Bezzina CR; Wilde AA
    J Mol Cell Cardiol; 2005 Jun; 38(6):969-81. PubMed ID: 15910881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mutation L619F in the cardiac Na+ channel SCN5A associated with long-QT syndrome (LQT3): a role for the I-II linker in inactivation gating.
    Wehrens XH; Rossenbacker T; Jongbloed RJ; Gewillig M; Heidbüchel H; Doevendans PA; Vos MA; Wellens HJ; Kass RS
    Hum Mutat; 2003 May; 21(5):552. PubMed ID: 12673799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substitution of a conserved alanine in the domain IIIS4-S5 linker of the cardiac sodium channel causes long QT syndrome.
    Smits JP; Veldkamp MW; Bezzina CR; Bhuiyan ZA; Wedekind H; Schulze-Bahr E; Wilde AA
    Cardiovasc Res; 2005 Aug; 67(3):459-66. PubMed ID: 16039271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biophysical characterization of a new SCN5A mutation S1333Y in a SIDS infant linked to long QT syndrome.
    Huang H; Millat G; Rodriguez-Lafrasse C; Rousson R; Kugener B; Chevalier P; Chahine M
    FEBS Lett; 2009 Mar; 583(5):890-6. PubMed ID: 19302788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac sodium channel overlap syndromes: different faces of SCN5A mutations.
    Remme CA; Wilde AA; Bezzina CR
    Trends Cardiovasc Med; 2008 Apr; 18(3):78-87. PubMed ID: 18436145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental aspects of long QT syndrome type 3 and Brugada syndrome on the basis of a single SCN5A mutation in childhood.
    Beaufort-Krol GC; van den Berg MP; Wilde AA; van Tintelen JP; Viersma JW; Bezzina CR; Bink-Boelkens MT
    J Am Coll Cardiol; 2005 Jul; 46(2):331-7. PubMed ID: 16022964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene-specific differences in the circadian variation of ventricular repolarization in the long QT syndrome: a key to sudden death during sleep?
    Stramba-Badiale M; Priori SG; Napolitano C; Locati EH; Viñolas X; Haverkamp W; Schulze-Bahr E; Goulene K; Schwartz PJ
    Ital Heart J; 2000 May; 1(5):323-8. PubMed ID: 10832806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrinsic mechanism of the enhanced rate-dependent QT shortening in the R1623Q mutant of the LQT3 syndrome.
    Oginosawa Y; Nagatomo T; Abe H; Makita N; Makielski JC; Nakashima Y
    Cardiovasc Res; 2005 Jan; 65(1):138-47. PubMed ID: 15621041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New perspectives in long QT syndrome].
    Medeiros-Domingo A; Iturralde-Torres P; Canizales-Quinteros S; Hernández-Cruz A; Tusié-Luna MT
    Rev Invest Clin; 2007; 59(1):57-72. PubMed ID: 17569301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.